Search research articles
Contact Us
Filters
Showing results (1571-1580 of 1,669) with videos related to
Page
of 167
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas
Eunice L Kwak, Janusz Jankowski, Sarah P Thayer, et al.
Plos One
|
May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats
Derek M Erion, Amanda Lapworth, Paul A Amor, et al.
Nature Ecology & Evolution
|
July 12, 2024
The nature of the last universal common ancestor and its impact on the early Earth system
Edmund R R Moody, Sandra Álvarez-Carretero, Tara A Mahendrarajah, et al.
Annals of Surgery
|
December 12, 2017
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
Theodoros Michelakos, Ilaria Pergolini, Carlos Fernández-Del Castillo, et al.
Science (New York, N.Y.)
|
April 3, 2025
A geological timescale for bacterial evolution and oxygen adaptation
Adrián A Davín, Ben J Woodcroft, Rochelle M Soo, et al.
Frontiers in Immunology
|
June 6, 2022
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, et al.
Practical Radiation Oncology
|
June 26, 2018
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis
Susan G R McDuff, Kyla A Remillard, Hui Zheng, et al.
The Oncologist
|
December 20, 2011
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
Darrell R Borger, Kenneth K Tanabe, Kenneth C Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2018
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Lipika Goyal, Hui Zheng, Thomas A Abrams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study
Christopher G Willett, Dan G Duda, Emmanuelle di Tomaso, et al.
Page
of 167
Search research articles
Search
Showing results (1571-1580 of 1,669) with videos related to
Sort By:
Page
of 167
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas
Eunice L Kwak, Janusz Jankowski, Sarah P Thayer, et al.
Plos One
|
May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats
Derek M Erion, Amanda Lapworth, Paul A Amor, et al.
Nature Ecology & Evolution
|
July 12, 2024
The nature of the last universal common ancestor and its impact on the early Earth system
Edmund R R Moody, Sandra Álvarez-Carretero, Tara A Mahendrarajah, et al.
Annals of Surgery
|
December 12, 2017
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
Theodoros Michelakos, Ilaria Pergolini, Carlos Fernández-Del Castillo, et al.
Science (New York, N.Y.)
|
April 3, 2025
A geological timescale for bacterial evolution and oxygen adaptation
Adrián A Davín, Ben J Woodcroft, Rochelle M Soo, et al.
Frontiers in Immunology
|
June 6, 2022
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, et al.
Practical Radiation Oncology
|
June 26, 2018
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis
Susan G R McDuff, Kyla A Remillard, Hui Zheng, et al.
The Oncologist
|
December 20, 2011
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
Darrell R Borger, Kenneth K Tanabe, Kenneth C Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2018
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Lipika Goyal, Hui Zheng, Thomas A Abrams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study
Christopher G Willett, Dan G Duda, Emmanuelle di Tomaso, et al.
Page
of 167